![Barbara Slusher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barbara Slusher
Berater bei JOHNSON & JOHNSON
Aktive Positionen von Barbara Slusher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
JOHNSON & JOHNSON | Berater | - | - |
Ashvattha Therapeutics Inc
![]() Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Ashvattha Therapeutics LLC provides healthcare services. The firm develops pharmaceutical products. The company is headquartered in Redwood City, CA. | Direktor/Vorstandsmitglied | - | - |
Catalio Capital Management LP
![]() Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - | - |
Eisai, Inc.
![]() Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Berater | - | - |
Bluefield Innovations LLC
![]() Bluefield Innovations LLC Financial ConglomeratesFinance Bluefield Innovations LLC engages in the commercialization and development of early stage therapeutic research. It includes basic research, proof of concept, target selection and investigational new drug (IND) enabling studies designed to qualify a candidate to enter into human clinical trials. The company was founded in November 2017 and is headquartered in New York, NY. | Berater | - | - |
Karriereverlauf von Barbara Slusher
Ehemalige bekannte Positionen von Barbara Slusher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Technik-/Wissenschafts-/F&E-Leiter | - | 03.10.2005 |
Adarga Ltd.
![]() Adarga Ltd. Packaged SoftwareTechnology Services Adarga Ltd. develops machine learning techniques to read and understand complex data. Its products include adarga_engine and adarga_bench. The company was founded by Robert Bassett Cross in 2016 and is headquartered in London, the United Kingdom. | Gründer | 01.01.2016 | - |
Dracen Pharmaceuticals, Inc.
![]() Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Gründer | - | - | |
AVALO THERAPEUTICS, INC. | Gründer | 31.01.2011 | - |
Ausbildung von Barbara Slusher
The Johns Hopkins University | Doctorate Degree |
Dickinson College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Vereinigtes Königreich | 2 |
Operativ
Consultant / Advisor | 3 |
Founder | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 7 |
---|---|
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Dracen Pharmaceuticals, Inc.
![]() Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Health Technology |
Ashvattha Therapeutics Inc
![]() Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Ashvattha Therapeutics LLC provides healthcare services. The firm develops pharmaceutical products. The company is headquartered in Redwood City, CA. | Health Technology |
Catalio Capital Management LP
![]() Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Eisai, Inc.
![]() Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Bluefield Innovations LLC
![]() Bluefield Innovations LLC Financial ConglomeratesFinance Bluefield Innovations LLC engages in the commercialization and development of early stage therapeutic research. It includes basic research, proof of concept, target selection and investigational new drug (IND) enabling studies designed to qualify a candidate to enter into human clinical trials. The company was founded in November 2017 and is headquartered in New York, NY. | Finance |
Adarga Ltd.
![]() Adarga Ltd. Packaged SoftwareTechnology Services Adarga Ltd. develops machine learning techniques to read and understand complex data. Its products include adarga_engine and adarga_bench. The company was founded by Robert Bassett Cross in 2016 and is headquartered in London, the United Kingdom. | Technology Services |
- Börse
- Insiders
- Barbara Slusher
- Erfahrung